APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Imaging Agents

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Molecular Imaging Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025174 pages

Choose your research edition.

Industry ResearchMolecular Imaging Agents Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Imaging Agents Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Molecular Imaging Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Imaging Agents Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Imaging Agents Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Molecular Imaging Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Molecular Imaging Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Molecular Imaging Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Molecular Imaging Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Molecular Imaging Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Molecular Imaging Agents include Eisai, Guerbet, General Electric and Bracco Diagnostic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Molecular Imaging Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Molecular Imaging Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Molecular Imaging Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Molecular Imaging Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Molecular Imaging Agents Segment by Company

Eisai

Guerbet

General Electric

Bracco Diagnostic

Molecular Imaging Agents Segment by Type

Engineered Protein Fragments

Nanoparticles

Aptamers

Peptides

Small Molecules

Others

Molecular Imaging Agents Segment by Application

Oncology

Cardiology

Gastrointestinal Disorders

Neurology Disorders

Others

Molecular Imaging Agents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Imaging Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Imaging Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Imaging Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Molecular Imaging Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Molecular Imaging Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Molecular Imaging Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Molecular Imaging Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Molecular Imaging Agents Industry Trends Table 2. Molecular Imaging Agents Industry Drivers Table 3. Molecular Imaging Agents Industry Opportunities and Challenges Table 4. Molecular Imaging Agents Industry Restraints Table 5. Global Molecular Imaging Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Molecular Imaging Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Molecular Imaging Agents Sales by Manufacturers (K Tons) & (2021-2026) Table 8. Global Molecular Imaging Agents Sales Market Share by Manufacturers Table 9. Global Molecular Imaging Agents Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Molecular Imaging Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Molecular Imaging Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Molecular Imaging Agents Manufacturers, Product Type & Application Table 13. Global Molecular Imaging Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Molecular Imaging Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Engineered Protein Fragments Table 17. Major Manufacturers of Nanoparticles Table 18. Major Manufacturers of Aptamers Table 19. Major Manufacturers of Peptides Table 20. Major Manufacturers of Small Molecules Table 21. Major Manufacturers of Others Table 22. Global Molecular Imaging Agents Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 23. Global Molecular Imaging Agents Sales by Type (2021-2026) & (K Tons) Table 24. Global Molecular Imaging Agents Sales by Type (2027-2032) & (K Tons) Table 25. Global Molecular Imaging Agents Sales Market Share by Type (2021-2026) Table 26. Global Molecular Imaging Agents Sales Market Share by Type (2027-2032) Table 27. Global Molecular Imaging Agents Revenue by Type 2021 VS 2025 VS 2032 (K Tons) Table 28. Global Molecular Imaging Agents Revenue by Type (2021-2026) & (K Tons) Table 29. Global Molecular Imaging Agents Revenue by Type (2027-2032) & (K Tons) Table 30. Global Molecular Imaging Agents Revenue Market Share by Type (2021-2026) Table 31. Global Molecular Imaging Agents Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Oncology Table 33. Major Manufacturers of Cardiology Table 34. Major Manufacturers of Gastrointestinal Disorders Table 35. Major Manufacturers of Neurology Disorders Table 36. Major Manufacturers of Others Table 37. Global Molecular Imaging Agents Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 38. Global Molecular Imaging Agents Sales by Application (2021-2026) & (K Tons) Table 39. Global Molecular Imaging Agents Sales by Application (2027-2032) & (K Tons) Table 40. Global Molecular Imaging Agents Sales Market Share by Application (2021-2026) Table 41. Global Molecular Imaging Agents Sales Market Share by Application (2027-2032) Table 42. Global Molecular Imaging Agents Revenue by Application 2021 VS 2025 VS 2032 (K Tons) Table 43. Global Molecular Imaging Agents Revenue by Application (2021-2026) & (K Tons) Table 44. Global Molecular Imaging Agents Revenue by Application (2027-2032) & (K Tons) Table 45. Global Molecular Imaging Agents Revenue Market Share by Application (2021-2026) Table 46. Global Molecular Imaging Agents Revenue Market Share by Application (2027-2032) Table 47. Global Molecular Imaging Agents Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 48. Global Molecular Imaging Agents Sales by Region (2021-2026) & (K Tons) Table 49. Global Molecular Imaging Agents Sales Market Share by Region (2021-2026) Table 50. Global Molecular Imaging Agents Sales Forecasted by Region (2027-2032) & (K Tons) Table 51. Global Molecular Imaging Agents Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Molecular Imaging Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 53. North America Molecular Imaging Agents Sales by Country (2021-2026) & (K Tons) Table 54. North America Molecular Imaging Agents Sales by Country (2027-2032) & (K Tons) Table 55. Europe Molecular Imaging Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 56. Europe Molecular Imaging Agents Sales by Country (2021-2026) & (K Tons) Table 57. Europe Molecular Imaging Agents Sales by Country (2027-2032) & (K Tons) Table 58. Asia Pacific Molecular Imaging Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 59. Asia Pacific Molecular Imaging Agents Sales by Country (2021-2026) & (K Tons) Table 60. Asia Pacific Molecular Imaging Agents Sales by Country (2027-2032) & (K Tons) Table 61. South America, Middle East and Africa Molecular Imaging Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 62. South America, Middle East and Africa Molecular Imaging Agents Sales by Country (2021-2026) & (K Tons) Table 63. South America, Middle East and Africa Molecular Imaging Agents Sales by Country (2027-2032) & (K Tons) Table 64. Global Molecular Imaging Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Molecular Imaging Agents Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Molecular Imaging Agents Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Molecular Imaging Agents Revenue Market Share by Region (2021-2026) Table 68. Global Molecular Imaging Agents Revenue Market Share by Region (2027-2032) Table 69. Eisai Company Information Table 70. Eisai Business Overview Table 71. Eisai Molecular Imaging Agents Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Eisai Molecular Imaging Agents Product Portfolio Table 73. Eisai Recent Development Table 74. Guerbet Company Information Table 75. Guerbet Business Overview Table 76. Guerbet Molecular Imaging Agents Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Guerbet Molecular Imaging Agents Product Portfolio Table 78. Guerbet Recent Development Table 79. General Electric Company Information Table 80. General Electric Business Overview Table 81. General Electric Molecular Imaging Agents Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. General Electric Molecular Imaging Agents Product Portfolio Table 83. General Electric Recent Development Table 84. Bracco Diagnostic Company Information Table 85. Bracco Diagnostic Business Overview Table 86. Bracco Diagnostic Molecular Imaging Agents Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Bracco Diagnostic Molecular Imaging Agents Product Portfolio Table 88. Bracco Diagnostic Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Molecular Imaging Agents Distributors List Table 92. Molecular Imaging Agents Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Molecular Imaging Agents Product Image Figure 2. Global Molecular Imaging Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Imaging Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Molecular Imaging Agents Sales (2021-2032) & (K Tons) Figure 5. Global Molecular Imaging Agents Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Molecular Imaging Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Engineered Protein Fragments Image Figure 9. Nanoparticles Image Figure 10. Aptamers Image Figure 11. Peptides Image Figure 12. Small Molecules Image Figure 13. Others Image Figure 14. Global Molecular Imaging Agents Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 15. Global Molecular Imaging Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Molecular Imaging Agents Sales Market Share by Type (2021-2032) Figure 17. Global Molecular Imaging Agents Revenue by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 18. Global Molecular Imaging Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Molecular Imaging Agents Revenue Market Share by Type (2021-2032) Figure 20. Oncology Image Figure 21. Cardiology Image Figure 22. Gastrointestinal Disorders Image Figure 23. Neurology Disorders Image Figure 24. Others Image Figure 25. Global Molecular Imaging Agents Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 26. Global Molecular Imaging Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Molecular Imaging Agents Sales Market Share by Application (2021-2032) Figure 28. Global Molecular Imaging Agents Revenue by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 29. Global Molecular Imaging Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Molecular Imaging Agents Revenue Market Share by Application (2021-2032) Figure 31. North America Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 32. North America Molecular Imaging Agents Sales Market Share by Country (2021-2032) Figure 33. U.S. Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 34. Canada Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 35. Mexico Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 36. Europe Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 37. Europe Molecular Imaging Agents Sales Market Share by Country (2021-2032) Figure 38. Germany Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 39. France Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 40. U.K. Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 41. Italy Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 42. Netherlands Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 43. Asia Pacific Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 44. Asia Pacific Molecular Imaging Agents Sales Market Share by Country (2021-2032) Figure 45. China Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 46. Japan Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 47. South Korea Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 48. Southeast Asia Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 49. India Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 50. Australia Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 51. South America, Middle East and Africa Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 52. South America, Middle East and Africa Molecular Imaging Agents Sales Market Share by Country (2021-2032) Figure 53. Brazil Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 54. South Africa Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 55. Saudi Arabia Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 56. Turkey Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 57. Argentina Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 58. UAE Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 59. Egypt Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 60. Chile Molecular Imaging Agents Sales and Growth Rate (2021-2032) & (K Tons) Figure 61. Global Molecular Imaging Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Molecular Imaging Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Molecular Imaging Agents Revenue (2021-2032) & (US$ Million) Figure 64. North America Molecular Imaging Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Molecular Imaging Agents Revenue (2021-2032) & (US$ Million) Figure 66. Europe Molecular Imaging Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Molecular Imaging Agents Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Molecular Imaging Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Molecular Imaging Agents Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Molecular Imaging Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Molecular Imaging Agents Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Molecular Imaging Agents Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Engineered Protein Fragments
  • Nanoparticles
  • Aptamers
  • Peptides
  • Small Molecules
  • Others
Applications
  • Oncology
  • Cardiology
  • Gastrointestinal Disorders
  • Neurology Disorders
  • Others
Companies covered
  • Eisai
  • Guerbet
  • General Electric
  • Bracco Diagnostic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Molecular Imaging Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Molecular Imaging Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Molecular Imaging Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Molecular Imaging Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Molecular Imaging Agents Market Dynamics
  1. 2.1 Molecular Imaging Agents Industry Trends
  2. 2.2 Molecular Imaging Agents Industry Drivers
  3. 2.3 Molecular Imaging Agents Industry Opportunities and Challenges
  4. 2.4 Molecular Imaging Agents Industry Restraints
3 Molecular Imaging Agents Market by Manufacturers
  1. 3.1 Global Molecular Imaging Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Molecular Imaging Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Molecular Imaging Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Molecular Imaging Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Molecular Imaging Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Molecular Imaging Agents Manufacturers, Product Type & Application
  7. 3.7 Global Molecular Imaging Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Molecular Imaging Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Molecular Imaging Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Molecular Imaging Agents Tier 1, Tier 2, and Tier 3
4 Molecular Imaging Agents Market by Type
  1. 4.1 Molecular Imaging Agents Type Introduction
  2. 4.1.1 Engineered Protein Fragments
  3. 4.1.2 Nanoparticles
  4. 4.1.3 Aptamers
  5. 4.1.4 Peptides
  6. 4.1.5 Small Molecules
  7. 4.1.6 Others
  8. 4.2 Global Molecular Imaging Agents Sales by Type
  9. 4.2.1 Global Molecular Imaging Agents Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Molecular Imaging Agents Sales by Type (2021-2032)
  11. 4.2.3 Global Molecular Imaging Agents Sales Market Share by Type (2021-2032)
  12. 4.3 Global Molecular Imaging Agents Revenue by Type
  13. 4.3.1 Global Molecular Imaging Agents Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Molecular Imaging Agents Revenue by Type (2021-2032)
  15. 4.3.3 Global Molecular Imaging Agents Revenue Market Share by Type (2021-2032)
5 Molecular Imaging Agents Market by Application
  1. 5.1 Molecular Imaging Agents Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Gastrointestinal Disorders
  5. 5.1.4 Neurology Disorders
  6. 5.1.5 Others
  7. 5.2 Global Molecular Imaging Agents Sales by Application
  8. 5.2.1 Global Molecular Imaging Agents Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Molecular Imaging Agents Sales by Application (2021-2032)
  10. 5.2.3 Global Molecular Imaging Agents Sales Market Share by Application (2021-2032)
  11. 5.3 Global Molecular Imaging Agents Revenue by Application
  12. 5.3.1 Global Molecular Imaging Agents Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Molecular Imaging Agents Revenue by Application (2021-2032)
  14. 5.3.3 Global Molecular Imaging Agents Revenue Market Share by Application (2021-2032)
6 Global Molecular Imaging Agents Sales by Region
  1. 6.1 Global Molecular Imaging Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Molecular Imaging Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Molecular Imaging Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Molecular Imaging Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Molecular Imaging Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Molecular Imaging Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Molecular Imaging Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Molecular Imaging Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Molecular Imaging Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Molecular Imaging Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Molecular Imaging Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Molecular Imaging Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Molecular Imaging Agents Revenue by Region
  1. 7.1 Global Molecular Imaging Agents Revenue by Region
  2. 7.1.1 Global Molecular Imaging Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Molecular Imaging Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Molecular Imaging Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Molecular Imaging Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Molecular Imaging Agents Revenue (2021-2032)
  8. 7.2.2 North America Molecular Imaging Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Molecular Imaging Agents Revenue (2021-2032)
  11. 7.3.2 Europe Molecular Imaging Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Molecular Imaging Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Molecular Imaging Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Molecular Imaging Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Molecular Imaging Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Molecular Imaging Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Molecular Imaging Agents Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Guerbet
  8. 8.2.1 Guerbet Company Information
  9. 8.2.2 Guerbet Business Overview
  10. 8.2.3 Guerbet Molecular Imaging Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Guerbet Molecular Imaging Agents Product Portfolio
  12. 8.2.5 Guerbet Recent Developments
  13. 8.3 General Electric
  14. 8.3.1 General Electric Company Information
  15. 8.3.2 General Electric Business Overview
  16. 8.3.3 General Electric Molecular Imaging Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 General Electric Molecular Imaging Agents Product Portfolio
  18. 8.3.5 General Electric Recent Developments
  19. 8.4 Bracco Diagnostic
  20. 8.4.1 Bracco Diagnostic Company Information
  21. 8.4.2 Bracco Diagnostic Business Overview
  22. 8.4.3 Bracco Diagnostic Molecular Imaging Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bracco Diagnostic Molecular Imaging Agents Product Portfolio
  24. 8.4.5 Bracco Diagnostic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Molecular Imaging Agents Value Chain Analysis
  2. 9.1.1 Molecular Imaging Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Molecular Imaging Agents Production Mode & Process
  6. 9.2 Molecular Imaging Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Molecular Imaging Agents Distributors
  9. 9.2.3 Molecular Imaging Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst